During the past decade, Gastro One - Germantown Office - Wolf Park Drive conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gastro One - Germantown Office - Wolf Park Drive" are "Non-Alcoholic Fatty Liver Disease" (2 trials) and "NASH - Nonalcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "Gastro One - Germantown Office - Wolf Park Drive" in a lesser frequency.

Most popular intervention types in "Gastro One - Germantown Office - Wolf Park Drive" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Resmetirom" (2 trials) and "IVA337" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastro One - Germantown Office - Wolf Park Drive" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Gastro One - Germantown Office - Wolf Park Drive". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Gastro One - Germantown Office - Wolf Park Drive, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastro One - Germantown Office - Wolf Park Drive, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".